Boothe Investment Group’s GoodRx Holdings GDRX Stock Holding History

Boothe Investment Group’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-212,324	Closed	-$992K	–	38
2022 Q3	$992K	Buy	212,324 +3,935	+2%	+$24.8K	0.64%	29
2022 Q2	$1.28M	Buy	208,389 +1,280	+0.6%	+$14.2K	1.08%	22
2022 Q1	$4.08M	Buy	207,109 +81,515	+65%	+$1.87M	2.81%	16
2021 Q4	$4.1M	Buy	+125,594	New	+$5.05M	2.19%	22

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Boothe Investment Group's GDRX Position: Q4 2022 in Review

Boothe Investment Group sold out of GoodRx Holdings (GDRX) in Q4 2022, closing a stake of 212,324 shares — an estimated $992K sold.

Boothe Investment Group first reported a position in GDRX in Q4 2021 and held it in 4 quarters. The position peaked at $4.1M in Q4 2021. 160 funds tracked by Wall St. Rank hold GDRX as of Q4 2022.

Boothe Investment Group reported no remaining GoodRx Holdings position as of Q4 2022 after selling out during the quarter.
Boothe Investment Group sold 212,324 GoodRx Holdings shares in Q4 2022, an estimated $992K.
Boothe Investment Group first reported a position in GoodRx Holdings in Q4 2021 and held it in 4 quarters.
Boothe Investment Group's GoodRx Holdings position peaked at $4.1M in Q4 2021.
160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2022.

Based on Boothe Investment Group's 13F filing for Q4 2022, filed 13 Feb 2023.